Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thaleia, Kalatha"'
Autor:
Thaleia Kalatha, Marianthi Arnaoutoglou, Theodoros Koukoulidis, Eleni Hatzifilippou, Emmanouil Bouras, Stavros Baloyannis, Effrosyni Koutsouraki
Publikováno v:
Journal of International Medical Research, Vol 47 (2019)
Objective To investigate whether neurofilament light polypeptide (NfL) level in cerebrospinal fluid (CSF), currently a prognostic biomarker of neurodegeneration in patients with multiple sclerosis (MS), may be a potential biomarker of cognitive dysfu
Externí odkaz:
https://doaj.org/article/b4bdb99e529747e386ca73162266c9c1
Autor:
Joyutpal Das, Thomas Lewis, William Lusher, Karen Vernon, David Rog, Talbot Paul, Nazar Sharaf, Thaleia Kalatha, Tatiana Mihalova
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 93:A26.1-A26
BackgroundNatalizumab has been used for treatment of rapidly evolving sever relapsing remitting multiple sclerosis (MS) and is associated with risk of progressive multifocal leukoencephalopathy (PML). Patients can switch treatment after two years if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0f486eb95d85e6cf32fbe7fa9a635a5
https://doi.org/10.1136/jnnp-2022-abn.79
https://doi.org/10.1136/jnnp-2022-abn.79
Autor:
Euphrosyni, Koutsouraki, Thaleia, Kalatha, Effrosyni, Grosi, Theodoros, Koukoulidis, Dimitrios, Michmizos
Publikováno v:
Hellenic journal of nuclear medicine.
Cognitive impairment is a common phenomenon in multiple sclerosis (MS), occurring at all stages of the disease, even at the earliest, and can be a major source of disability, social impairment, and impoverished quality of life. Cognitive dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a162664d7985e72d258f05d0db14383c
https://pubmed.ncbi.nlm.nih.gov/30877725
https://pubmed.ncbi.nlm.nih.gov/30877725